Moderna wins EU approval for its COVID-19-flu combo shot mCombriax, backed by strong phase III data showing superior immune ...

In the U.S., Moderna withdrew its approval application for the combination vaccine in May last year and the timeline for ...

Older adults across the European Union are a step closer to replacing two annual jabs with one. In late February 2026, the ...

A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now ...

The American pharmaceutical and biotechnology company Moderna has initiated a large clinical trial around a vaccine designed ...

Recent developments in the health sector include Moderna's EU approval for a combined flu and COVID-19 vaccine, acquisition dynamics in Vietnam's medical market, and judicial impacts on U.S. vaccine ...

Sheila Cherfilus-McCormick (D-Fla.) resigned from Congress; she and her brother are alleged to have stolen $5 million from ...

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...

Bird flu vaccine trial begins to fight ‘real possibility’ of virus threat for humans - The vaccine will utilise mRNA ...

Members of the public who spend a significant amount of time with chickens or other birds are being encouraged to sign up for ...

Around 3,000 UK volunteers will receive the jab.

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.